Medizinische Universität Graz - Research portal
Pieber Thomas |
Total: 177 project(s)
of which:
- Current: 14 project(s)
- Completed: 163 project(s)
- Publicly accessible: 34 project(s)
- Funded projects: 36 project(s)
- scient. event(s): 0 project(s)
- 174 project(s) as project manager and 3 project(s) as project member
- Project type: EN: Forschungsförderung
- Project Leader: Pieber Thomas
- MUG Research Units: Division of Endocrinology and Diabetology ;
- Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
- Duration: 01.05.2022-30.04.2026
- Project type: EN: Forschungsförderung
- Project Leader: Pieber Thomas
- MUG Research Units: Division of Endocrinology and Diabetology ;
- Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
- Duration: 01.11.2023-31.10.2028
- Project type: EN: Forschungsförderung
- Project Leader: Pieber Thomas
- MUG Research Units: Division of Endocrinology and Diabetology ;
- Funded by: FWF, Fonds zur Förderung der Wissenschaftlichen Forschung, Wien, Austria
- Duration: 01.10.2024-30.09.2029
- Project type: EN: Forschungsförderung
- Project Leader: Pieber Thomas
- MUG Research Units: Division of Endocrinology and Diabetology ;
- Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
- Duration: 01.02.2025-31.01.2029
- Project type: EN: Forschungsförderung
- Project Leader: Pieber Thomas
- MUG Research Units: Division of Endocrinology and Diabetology ;
- Funded by: JDRF - Juvenile Diabetes Research Foundation, 200 Vesey Street, New York, United States (USA)
- Duration: 01.01.2025-31.12.2027
-
Next generation in-blood glucose monitoring using non-invasive optoacoustic sensing
-
European action for the Diagnosis of Early Non-symptomatic Type 1 diabetes For Intervention
-
Metabolic control of aging and disease: From Models to humans
-
Multivariate optoacoustic sensor for longitudinal diabetes monitoring
-
An open-label extension multi-centre trial in adult subjects diagnosed with Type 1 diabetes mellitus exploring the effect of long-term Verapamil SR therapy on the preservation of beta cell function.